Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Market response today

<< Previous

Bullboard Posts

Next >>

Comment by bee6mc1on Nov 30, 2021 7:21am

116 Views

Post# 34178996

RE:Market response today

This is very typical for a Canadian biotech. If on the nasdaq it would be at $5.00. Cannabis is the best pain relief for cancer pain!!! I hold 93,000 at 0.35c. I will be rich!!! 200 billion cancer pain market...total pain market off label 1 trillion. This is so safe it will beside the Tylenol.

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec